MS drug safety study halted early after just 4 patients
Symptom relief
Terminated
This early-stage study tested whether a single dose of bryostatin is safe for people with multiple sclerosis who are already taking standard treatments. Only 4 participants were enrolled before the study was stopped. The main goal was to track side effects, not to measure if the …
Phase: PHASE1 • Sponsor: Robert Fox • Aim: Symptom relief
Last updated May 04, 2026 16:19 UTC